Lau C B S, Ho C Y, Kim C F, Leung K N, Fung K P, Tse T F, Chan H H L, Chow M S S
School of Pharmacy, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Life Sci. 2004 Jul 2;75(7):797-808. doi: 10.1016/j.lfs.2004.04.001.
Coriolus versicolor (CV), also known as Yunzhi, is one of the commonly used Chinese medicinal herbs. Although recent studies have demonstrated its antitumour activities on cancer cells in vitro and in vivo, the exact mechanism is not fully elucidated. Hence, the objective of this study was to examine the in vitro cytotoxic activities of a standardized aqueous ethanol extract prepared from Coriolus versicolor on a B-cell lymphoma (Raji) and two human promyelocytic leukemia (HL-60, NB-4) cell lines using a MTT cytotoxicity assay, and to test whether the mechanism involves induction of apoptosis. Cell death ELISA was employed to quantify the nucleosome production resulting from nuclear DNA fragmentation during apoptosis. The present results demonstrated that CV extract at 50 to 800 microg/ml dose-dependently suppressed the proliferation of Raji, NB-4, and HL-60 cells by more than 90% (p < 0.01), with ascending order of IC50 values: HL-60 (147.3 +/- 15.2 microg/ml), Raji (253.8 +/- 60.7 microg/ml) and NB-4 (269.3 +/- 12.4 microg/ml). The extract however did not exert any significant cytotoxic effect on normal liver cell line WRL (IC50 > 800 microg/ml) when compared with a chemotherapeutic anticancer drug, mitomycin C (MMC), confirming the tumour-selective cytotoxicity. Nucleosome productions in HL-60, NB-4 and Raji cells were significantly increased by 3.6-, 3.6- and 5.6-fold respectively upon the treatment of CV extract, while no significant nucleosome production was detected in extract-treated WRL cells. The CV extract was found to selectively and dose-dependently inhibit the proliferation of lymphoma and leukemic cells possibly via an apoptosis-dependent pathway.
云芝,又称杂色云芝,是常用的中药材之一。尽管最近的研究已证明其在体外和体内对癌细胞具有抗肿瘤活性,但其确切机制尚未完全阐明。因此,本研究的目的是使用MTT细胞毒性测定法,检测从云芝制备的标准化水乙醇提取物对B细胞淋巴瘤(Raji)和两个人早幼粒细胞白血病(HL-60、NB-4)细胞系的体外细胞毒性活性,并测试其机制是否涉及诱导细胞凋亡。采用细胞死亡ELISA法量化凋亡过程中核DNA片段化产生的核小体生成量。目前的结果表明,50至800μg/ml剂量的云芝提取物剂量依赖性地抑制Raji、NB-4和HL-60细胞的增殖,抑制率超过90%(p<0.01),IC50值升序排列为:HL-60(147.3±15.2μg/ml)、Raji(253.8±60.7μg/ml)和NB-4(269.3±12.4μg/ml)。然而,与化疗抗癌药物丝裂霉素C(MMC)相比,该提取物对正常肝细胞系WRL没有任何显著的细胞毒性作用(IC50>800μg/ml),证实了其肿瘤选择性细胞毒性。用云芝提取物处理后,HL-60、NB-4和Raji细胞中的核小体生成量分别显著增加了3.6倍、3.6倍和5.6倍,而在提取物处理的WRL细胞中未检测到显著的核小体生成。发现云芝提取物可能通过凋亡依赖性途径选择性地且剂量依赖性地抑制淋巴瘤和白血病细胞的增殖。